LogicBio Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2014-01-01
- Employees
- 62
- Market Cap
- -
- Website
- http://www.logicbio.com
Long-term Follow-up Study of Patients Who Received hLB-001 Gene Therapy
- First Posted Date
- 2022-08-18
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- LogicBio Therapeutics, Inc
- Target Recruit Count
- 4
- Registration Number
- NCT05506254
- Locations
- 🇺🇸
Clinical Trial Site, Seattle, Washington, United States
Gene Therapy With hLB-001 in Pediatric Patients With Severe Methylmalonic Acidemia
Phase 1
Terminated
- Conditions
- Methylmalonic Acidemia
- Interventions
- Biological: hLB-001
- First Posted Date
- 2020-10-09
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- LogicBio Therapeutics, Inc
- Target Recruit Count
- 4
- Registration Number
- NCT04581785
- Locations
- 🇺🇸
Clinical Trial Site, Seattle, Washington, United States
© Copyright 2025. All Rights Reserved by MedPath